Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus.
Lab research · 2006
- What was studied
- Human T-cell cultures exposed to tumor-conditioned medium or measles virus
- Main finding
- MP-2 (LVVYPW) restored IL-2 production and receptor expression in experimentally suppressed human T cells. Human-derived cells do not make this a human treatment trial.
Study data at a glance
- Participants or experimental model
- Human T-cell cultures exposed to tumor-conditioned medium or measles virus
- Reported results
- MP-2 (LVVYPW) restored IL-2 production and receptor expression in experimentally suppressed human T cells. Human-derived cells do not make this a human treatment trial.
Study limitations and source details
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Source details
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Abstract reviewed
Sources checked
Citation
Mikhailova AA, Belevskaya RG, Kalyuzhnaya M, Fonina LA, Liashenko VA, Petrov RV. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus. Journal of immunotherapy (Hagerstown, Md. : 1997)
Study source ↗ · DOI 10.1097/01.cji.0000188366.84341.c3 · Bibliography entry · Link to this summary